Success Metrics

Clinical Success Rate

90.9%

Based on 10 completed trials

Completion Rate

91%(10/11)

Active Trials

0(0%)

Results Posted

20%(2 trials)

Terminated

1(8%)

Phase Distribution

Ph phase_3

23%

Ph early_phase_1

Ph not_applicable

Ph phase_4

Ph phase_1

15%

Ph phase_2

23%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

1(9.1%)

Phase 1Safety & dosage

2(18.2%)

Phase 2Efficacy & side effects

3(27.3%)

Phase 3Large-scale testing

3(27.3%)

Phase 4Post-market surveillance

1(9.1%)

N/ANon-phased studies

1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(10)

Terminated(1)

Other(2)

Detailed Status

Completed10

unknown2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (9.1%)

Phase 12 (18.2%)

Phase 23 (27.3%)

Phase 33 (27.3%)

Phase 41 (9.1%)

N/A1 (9.1%)

Trials by Status

completed1077%

terminated18%

unknown215%

Recent Activity

0 active trials

Showing 5 of 13

completedphase_2

Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

NCT02836925

completedphase_3

Clinical Trials (13)

Showing 13 of 13 trials

NCT02836925Phase 2

Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

Completed

NCT02660905Phase 3

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Completed

NCT02555943Phase 2

DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)

Completed

NCT02683005Phase 1

Study of Hepatitis C Treatment During Pregnancy

Completed

NCT03721627Phase 4

Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.

Unknown

NCT02597166Phase 3

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Completed

NCT02758509

Impact of Antiviral Therapy on Gastroesophageal Varices.

Completed

NCT02605304Phase 2

12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF

Terminated

NCT02128217Phase 1

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

Completed

NCT02576314Phase 3

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients

Completed

NCT03169348Not Applicable

The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia

Unknown

NCT03188276Early Phase 1

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Completed

NCT03063723

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

Completed

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13